PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: iCube (iCube+)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Prosol S.p.A. at Food Ingredients Europe & Natural Ingredients 2015 in Paris - Prosol S.p.A. will attend Fi Europe & Ni on the 1-3th December 2015. A great opportunity to stay tuned on the latest news about industry trends and the changing of nutraceuticals market - Prosol-spa.it
Prosol S.p.A. at Food Ingredients Europe & Natural Ingredients 2015 in Paris

 

NewswireToday - /newswire/ - Catania, Italy, 2015/10/22 - Prosol S.p.A. will attend Fi Europe & Ni on the 1-3th December 2015. A great opportunity to stay tuned on the latest news about industry trends and the changing of nutraceuticals market - Prosol-spa.it.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Prosol S.p.A., the Italian biotechnology company based in Madone, will be present at Food Ingredients Europe & Natural Ingredients 2015 on 1-3rd December in Paris, France. The event brings together the world's leading ingredients suppliers, distributors and buyers from the food and beverage industry and is considered as one of the top 10 most important events of the Food & Beverage industry, with exhibitors from all around the world. The event would be a great opportunity to stay tuned on the latest news about industry trends and the changing of nutraceuticals market. The Trade Show is organized biennially and Prosol has already successfully participated at the 2009 and 2011 editions: this year Prosol is again ready to meet Technical and R&D Managers in order to share its vision and start mutually useful relationships at FIE.
During Fi Europe & Ni 2015 Prosol’s experts will be able to help you and your business finding the best ingredients designed to cover your customer needs, and selecting the most innovative solutions in key areas like immune health, natural ingredients and salt reduction, baby food, supplements & nutraceuticals.
Prosol selects ingredients for the improvement of the functional and nutritional values of foods, offering the following advantages: immune modulation improvement in infant formula and dietary supplements (with Yeasts’ Nucleic Acids and Nucleotides); improvement in taste profile, monosodium glutamate replacement and salt reduction (with natural flavour enhancers);.

PROSOL: COMPANY PROFILE
Prosol (prosol-spa.it) develops innovative nutritional ingredients for the food and the nutraceutical industry. Prosol is a reputed leader in the production of Yeast's Ribonucleic Acid (RNA) and derivatives rich in natural 5'-nucleotides effective in immunity and flavour enhancing. Prosol has an in-house developed technology and its production is totally sustainable, without the use of chemical solvents. Prosol selects and mixes 5'-nucleotides for infant formula. The Company has also gained the ISO, IFS and OHSAS certifications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: iCube (iCube+)

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Prosol S.p.A. at Food Ingredients Europe & Natural Ingredients 2015 in Paris

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Laura Fassari - iCubePlus.com 
+39 344173304 prosol[.]prosol-spa.it
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any iCube (iCube+) securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From iCube (iCube+) / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)